BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 16189255)

  • 21. Results of two years of growth hormone treatment followed by combined growth hormone and oestradiol in Turner syndrome. The Norwegian Turner Study Group.
    Knudtzon J; Aarskog D
    Horm Res; 1993; 39 Suppl 2():7-17. PubMed ID: 8395456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
    Mauras N; Attie KM; Reiter EO; Saenger P; Baptista J
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Growth hormone therapy in Turner's syndrome: an update on final height. Genentech National Cooperative Study Group.
    Rosenfeld RG
    Acta Paediatr Suppl; 1992 Sep; 383():3-6; discussion 7. PubMed ID: 1458013
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Normalization of puberty and adult height in girls with Turner syndrome: results of the Swedish Growth Hormone trials initiating transition into adulthood.
    Kriström B; Ankarberg-Lindgren C; Barrenäs ML; Nilsson KO; Albertsson-Wikland K
    Front Endocrinol (Lausanne); 2023; 14():1197897. PubMed ID: 37529614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Late or delayed induced or spontaneous puberty in girls with Turner syndrome treated with growth hormone does not affect final height.
    Massa G; Heinrichs C; Verlinde S; Thomas M; Bourguignon JP; Craen M; François I; Du Caju M; Maes M; De Schepper J;
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4168-74. PubMed ID: 12970282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adult height and pubertal growth in Turner syndrome after treatment with recombinant growth hormone.
    Soriano-Guillen L; Coste J; Ecosse E; Léger J; Tauber M; Cabrol S; Nicolino M; Brauner R; Chaussain JL; Carel JC
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5197-204. PubMed ID: 15998771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth response and levels of growth factors after two years growth hormone treatment are similar for a once and twice daily injection regimen in girls with Turner syndrome. (Dutch Working Group on Growth Hormone).
    van Teunenbroek A; de Muinck Keizer-Schrama S; Stijnen T; Waelkens J; Wit JM; Vulsma T; Gerver WJ; Reeser H; Delemarre-van de Waal H; Jansen M; Drop S
    Clin Endocrinol (Oxf); 1997 Apr; 46(4):451-9. PubMed ID: 9196608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Body composition and physical fitness are major determinants of the growth hormone-insulin-like growth factor axis aberrations in adult Turner's syndrome, with important modulations by treatment with 17 beta-estradiol.
    Gravholt CH; Naeraa RW; Fisker S; Christiansen JS
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2570-7. PubMed ID: 9253336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of conventional dose growth hormone therapy for two years on height velocity and height prognosis in girls with Turner syndrome.
    Lenko HL; Hakulinen A; Käär ML; Mäenpää J; Mäkelä AL; Sipilä I
    Horm Res; 1993; 39 Suppl 2():3-6. PubMed ID: 8395455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination growth hormone and estrogen increase bone mineralization in girls with Turner syndrome.
    Beckett PR; Copeland KC; Flannery TK; Sherman LD; Abrams SA
    Pediatr Res; 1999 May; 45(5 Pt 1):709-13. PubMed ID: 10231869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum growth hormone (GH)-binding protein and insulin-like growth factor-I levels in Turner's syndrome before and during treatment with recombinant human GH and ethinyl estradiol.
    Massa G; Bouillon R; Vanderschueren-Lodeweyckx M
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1298-302. PubMed ID: 1430092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of growth hormone supplementation on adult height in turner syndrome: results of the Canadian randomized controlled trial.
    Stephure DK;
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3360-6. PubMed ID: 15784709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of short term treatment with growth hormone and ethinyl estradiol on lower leg growth rate in girls with Turner's syndrome.
    Ross JL; Cassorla F; Carpenter G; Long LM; Royster MS; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1988 Sep; 67(3):515-8. PubMed ID: 3410937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A multicentre trial of recombinant growth hormone and low dose oestrogen in Turner syndrome: near final height analysis.
    Johnston DI; Betts P; Dunger D; Barnes N; Swift PG; Buckler JM; Butler GE
    Arch Dis Child; 2001 Jan; 84(1):76-81. PubMed ID: 11124794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of growth hormone therapy on adult height of children with Turner syndrome.
    Hsu PY; Tung YC; Tsai WY; Lee JS; Hsiao PH
    J Formos Med Assoc; 2008 Sep; 107(9):704-9. PubMed ID: 18796360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment.
    Bannink EM; van Doorn J; Stijnen T; Drop SL; de Muinck Keizer-Schrama SM
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):310-9. PubMed ID: 16918949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone.
    Pasquino AM; Pucarelli I; Roggini M; Segni M
    J Clin Endocrinol Metab; 2000 Feb; 85(2):619-22. PubMed ID: 10690865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Optimizing estrogen treatment in Turner syndrome].
    Ságodi L; Sólyom E
    Orv Hetil; 2003 Mar; 144(12):563-8. PubMed ID: 12723527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of growth hormone and 17beta-oestradiol treatment on metabolism and body composition in girls with Turner syndrome.
    Gravholt CH; Hjerrild BE; Naeraa RW; Engbaek F; Mosekilde L; Christiansen JS
    Clin Endocrinol (Oxf); 2005 May; 62(5):616-22. PubMed ID: 15853835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Morning versus evening administration of estradiol to girls with turner syndrome receiving growth hormone: impact on growth hormone and metabolism. A randomized placebo-controlled crossover study.
    Naeraa RW; Gravholt CH; Kastrup KW; Svenstrup B; Christiansen JS
    Acta Paediatr; 2001 May; 90(5):526-31. PubMed ID: 11430712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.